AMRN
Price
$0.42
Change
-$0.01 (-2.33%)
Updated
Apr 3 closing price
Capitalization
357.53M
26 days until earnings call
MBRX
Price
$0.87
Change
-$0.09 (-9.38%)
Updated
Apr 3 closing price
Capitalization
11.56M
Ad is loading...

AMRN vs MBRX

Header iconAMRN vs MBRX Comparison
Open Charts AMRN vs MBRXBanner chart's image
Amarin
Price$0.42
Change-$0.01 (-2.33%)
Volume$1.49M
Capitalization357.53M
Moleculin Biotech
Price$0.87
Change-$0.09 (-9.38%)
Volume$336.88K
Capitalization11.56M
AMRN vs MBRX Comparison Chart
Loading...
AMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MBRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMRN vs. MBRX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRN is a Hold and MBRX is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (AMRN: $0.42 vs. MBRX: $0.87)
Brand notoriety: AMRN: Notable vs. MBRX: Not notable
AMRN represents the Pharmaceuticals: Major, while MBRX is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMRN: 104% vs. MBRX: 4%
Market capitalization -- AMRN: $357.53M vs. MBRX: $11.56M
AMRN [@Pharmaceuticals: Major] is valued at $357.53M. MBRX’s [@Biotechnology] market capitalization is $11.56M. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMRN’s FA Score shows that 0 FA rating(s) are green whileMBRX’s FA Score has 0 green FA rating(s).

  • AMRN’s FA Score: 0 green, 5 red.
  • MBRX’s FA Score: 0 green, 5 red.
According to our system of comparison, MBRX is a better buy in the long-term than AMRN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMRN’s TA Score shows that 4 TA indicator(s) are bullish while MBRX’s TA Score has 2 bullish TA indicator(s).

  • AMRN’s TA Score: 4 bullish, 6 bearish.
  • MBRX’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, both AMRN and MBRX are a bad buy in the short-term.

Price Growth

AMRN (@Pharmaceuticals: Major) experienced а -9.27% price change this week, while MBRX (@Biotechnology) price change was -17.27% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.77%. For the same industry, the average monthly price growth was -3.24%, and the average quarterly price growth was -8.16%.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.91%. For the same industry, the average monthly price growth was -11.19%, and the average quarterly price growth was -14.86%.

Reported Earning Dates

AMRN is expected to report earnings on Apr 30, 2025.

MBRX is expected to report earnings on May 09, 2024.

Industries' Descriptions

@Pharmaceuticals: Major (-1.77% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

@Biotechnology (-8.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMRN($358M) has a higher market cap than MBRX($11.6M). AMRN YTD gains are higher at: -12.866 vs. MBRX (-48.900). MBRX has higher annual earnings (EBITDA): -28.79M vs. AMRN (-50.7M). AMRN has more cash in the bank: 321M vs. MBRX (9.41M). MBRX has less debt than AMRN: MBRX (506K) vs AMRN (8.74M). AMRN has higher revenues than MBRX: AMRN (307M) vs MBRX (0).
AMRNMBRXAMRN / MBRX
Capitalization358M11.6M3,086%
EBITDA-50.7M-28.79M176%
Gain YTD-12.866-48.90026%
P/E Ratio67.11N/A-
Revenue307M0-
Total Cash321M9.41M3,413%
Total Debt8.74M506K1,727%
FUNDAMENTALS RATINGS
AMRN vs MBRX: Fundamental Ratings
AMRN
MBRX
OUTLOOK RATING
1..100
782
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
36
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9499
PRICE GROWTH RATING
1..100
8794
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MBRX's Valuation (36) in the Pharmaceuticals Major industry is somewhat better than the same rating for AMRN (88) in the Pharmaceuticals Other industry. This means that MBRX’s stock grew somewhat faster than AMRN’s over the last 12 months.

MBRX's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as AMRN (100) in the Pharmaceuticals Other industry. This means that MBRX’s stock grew similarly to AMRN’s over the last 12 months.

AMRN's SMR Rating (94) in the Pharmaceuticals Other industry is in the same range as MBRX (99) in the Pharmaceuticals Major industry. This means that AMRN’s stock grew similarly to MBRX’s over the last 12 months.

AMRN's Price Growth Rating (87) in the Pharmaceuticals Other industry is in the same range as MBRX (94) in the Pharmaceuticals Major industry. This means that AMRN’s stock grew similarly to MBRX’s over the last 12 months.

AMRN's P/E Growth Rating (100) in the Pharmaceuticals Other industry is in the same range as MBRX (100) in the Pharmaceuticals Major industry. This means that AMRN’s stock grew similarly to MBRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMRNMBRX
RSI
ODDS (%)
Bullish Trend 1 day ago
75%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
79%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 9 days ago
71%
Bullish Trend 24 days ago
75%
Declines
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
84%
Aroon
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
85%
View a ticker or compare two or three
Ad is loading...
AMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MBRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EVAX1.69N/A
N/A
Evaxion Biotech A/S
AVY176.34-4.24
-2.35%
Avery Dennison Corp
STRS16.51-1.27
-7.14%
Stratus Properties
BTDR8.77-0.71
-7.49%
Bitdeer Technologies Group
BHF54.99-4.79
-8.01%
Brighthouse Financial

AMRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMRN has been loosely correlated with KZR. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if AMRN jumps, then KZR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMRN
1D Price
Change %
AMRN100%
-2.18%
KZR - AMRN
56%
Loosely correlated
-2.17%
CNTB - AMRN
55%
Loosely correlated
-6.44%
HRTX - AMRN
44%
Loosely correlated
-4.04%
MGNX - AMRN
44%
Loosely correlated
-5.74%
ALXO - AMRN
43%
Loosely correlated
-10.48%
More

MBRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MBRX has been loosely correlated with EDSA. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if MBRX jumps, then EDSA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MBRX
1D Price
Change %
MBRX100%
-9.60%
EDSA - MBRX
36%
Loosely correlated
-5.31%
AMRN - MBRX
32%
Poorly correlated
-2.18%
DOMH - MBRX
30%
Poorly correlated
-9.95%
AXON - MBRX
29%
Poorly correlated
-3.35%
VKTX - MBRX
29%
Poorly correlated
-5.69%
More